908 Devices Inc.
For the period ended Jun 30, 2025. Filed Aug 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 5, 2025
MASS$9.99-13.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In thousands)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Six Months Ended June 30, | ||||||
| · 2025 · 2024 | ||||||
| Cash flows from operating activities: · · · · | ||||||
| Net income (loss) | | $30,297 | | $(23,465) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | | | | | ||
| Depreciation and amortization expense | | 2,263 | | 1,832 | ||
| Stock-based compensation expense | | 4,701 | | 5,739 | ||
| Provision for inventory obsolescence | | 209 | | 229 | ||
| Net amortization of premiums and accretion of discounts on marketable securities | | | (385) | | | (87) |
| Loss on disposal of property and equipment | | | 95 | | | 28 |
| Gain on sale of Desktop Portfolio, net of transaction costs | | | (56,200) | | | — |
| Provision for credit losses | | | 28 | | | 190 |
| Change in fair value of contingent consideration | | | 9,291 | | | — |
| Deferred income tax | | | — | | | (138) |
| Changes in operating assets and liabilities, net of business combinations: | | | | | ||
| Accounts receivable, net | | 5,327 | | (1,260) | ||
| Inventory | | (5,153) | | (3,073) | ||
| Prepaid expenses and other current assets | | (3,317) | | 740 | ||
| Other long-term assets | | 181 | | 35 | ||
| Accounts payable and accrued expenses | | (5,641) | | (1,443) | ||
| Deferred revenue | | (2,436) | | (1,698) | ||
| Right-of-use operating lease assets | | 1,421 | | 962 | ||
| Operating lease liabilities | | (1,484) | | (988) | ||
| Net cash used in operating activities | | (20,803) | | (22,397) | ||
| Cash flows from investing activities: | | | | | ||
| Purchases of property and equipment | | (281) | | (256) | ||
| Purchases of marketable securities | | | (59,417) | | | (30,208) |
| Acquisition of RedWave Technology, net of cash acquired | | | — | | | (44,783) |
| Proceeds from sale of Desktop Portfolio | | | 69,917 | | | — |
| Proceeds from maturities of marketable securities | | | 28,507 | | | 24,356 |
| Net cash provided by (used in) investing activities | | 38,726 | | (50,891) | ||
| Cash flows from financing activities: | | | | | ||
| Payments for withholding taxes on vested awards | | | (655) | | | (996) |
| Proceeds from issuance of common stock | | | 388 | | | 485 |
| Payments for contingent consideration | | | — | | | (417) |
| Net cash used in financing activities | | (267) | | (928) | ||
| Effect of foreign exchange rate changes on cash and cash equivalents | | | 27 | | | (14) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | | 17,683 | | (74,230) | ||
| Cash, cash equivalents and restricted cash at beginning of period | | 44,203 | | 121,212 | ||
| Cash, cash equivalents and restricted cash at end of period | | $61,886 | | $46,982 | ||
| Supplemental disclosure of noncash investing and financing information: | | | | | ||
| Property and equipment included in account payable | | $169 | | $— | ||
| Transfers of inventory to property and equipment | | $238 | | $589 | ||
| Fair value of common stock issued for acquisition of RedWave Technology | | $— | | $8,616 | ||
| Reconciliation of cash, cash equivalents and restricted cash: | | | | | | |
| Cash and cash equivalents | | $61,751 | | $46,811 | ||
| Restricted cash included in other long-term assets | | | 135 | | | 171 |
| Total cash, cash equivalents and restricted cash shown in the statement of cash flows | | $61,886 | | $46,982 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.